Christopher Kenney
Chief Tech/Sci/R&D Officer at XENON PHARMACEUTICALS INC.
Net worth: - $ as of 2024-06-29
Network origin in Christopher Kenney first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 | |
| Public Company | Pharmaceuticals: Major | 9 | |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Biotie Therapies, Inc.
1
| Subsidiary | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christopher Kenney via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Medical Specialties | Corporate Officer/Principal | |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DYAX CORP. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CURIS, INC. | Biotechnology | Corporate Officer/Principal | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Investor Relations Contact | |
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Chief Operating Officer | |
| University of Virginia | College/University | Undergraduate Degree Undergraduate Degree | |
| GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Executive Officer Consultant / Advisor | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Chief Operating Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| Mount Holyoke College | College/University | Undergraduate Degree | |
| University of British Columbia | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Masters Business Admin | |
| University of Cape Town | College/University | Undergraduate Degree Doctorate Degree | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Director/Board Member | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Michael Smith Foundation for Health Research
 Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| COGNITION THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Public Communications Contact Chairman | |
| Centre for Molecular Medicine & Therapeutic | Director/Board Member Founder | ||
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Tarix Orphan LLC
 Tarix Orphan LLC Pharmaceuticals: MajorHealth Technology Tarix Orphan LLC is a pharmaceutical company that manufactures pharmaceutical formulation products. The private company is based in Cambridge, MA. The company was founded by Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Pharmaceuticals: Major | President | |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Chairman | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Xenon Pharmaceuticals USA, Inc.
 Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Pharmaceuticals: Major | President Director/Board Member | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer | |
NeuroTrauma Sciences LLC
 NeuroTrauma Sciences LLC Pharmaceuticals: MajorHealth Technology NeuroTrauma Sciences LLC operates as a biopharmaceutical company. It develops neuroprotective and neurorestorative agents to treat brain injury. The company was founded by Carl Long in July 2016 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PERIMETER MEDICAL IMAGING AI, INC. | Medical Specialties | Director/Board Member Investor Relations Contact | |
| ACELYRIN, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Director/Board Member | |
| GARDINER HEALTHCARE ACQUISITIONS CORP. | Financial Conglomerates | Corporate Officer/Principal | |
| Morrison Advisory Consulting | Founder |
Statistics
International
| United States | 39 |
| Canada | 6 |
| United Kingdom | 4 |
| Switzerland | 3 |
| South Africa | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 4 |
| Government | 2 |
Operational
| Director/Board Member | 143 |
| Corporate Officer/Principal | 100 |
| Independent Dir/Board Member | 57 |
| Chief Tech/Sci/R&D Officer | 41 |
| Undergraduate Degree | 30 |
Most connected contacts
| Insiders | |
|---|---|
| Clarence Machado | 31 |
| Michael Hayden | 27 |
| Dave Grayzel | 23 |
| Simon Pimstone | 22 |
| Jodie Morrison | 21 |
| Mohammad Azab | 21 |
| Dawn Svoronos | 19 |
| Gary Patou | 17 |
| John McBride | 17 |
| Michael Rogers | 16 |
| Steven Gannon | 14 |
| Benedict Osorio | 12 |
| Gillian Cannon | 11 |
| Elizabeth Garofalo | 11 |
| Michael Samar | 10 |
- Stock Market
- Insiders
- Christopher Kenney
- Company connections
